Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 2 1

Status

Recruiting 5Active not recruiting 5

Sponsor Class

OTHER 2NIH 2INDUSTRY 1

Study Type

Interventional 3Observational 2

Sponsor

Cancer Type

Endocrine 5

Conditions

Breast Neoplasms 266Neoplasms 231Carcinoma, Non-Small-Cell Lung 209Colorectal Neoplasms 155Prostatic Neoplasms 148Lung Neoplasms 121Neoplasm Metastasis 112Ovarian Neoplasms 105Multiple Myeloma 98Pancreatic Neoplasms 91Leukemia, Myeloid, Acute 82Squamous Cell Carcinoma of Head and Neck 76Endometrial Neoplasms 67Melanoma 66Stomach Neoplasms 63Glioblastoma 61Recurrence 58Brain Neoplasms 56Carcinoma, Hepatocellular 53Urinary Bladder Neoplasms 52Precursor Cell Lymphoblastic Leukemia-Lymphoma 51Head and Neck Neoplasms 51Carcinoma, Renal Cell 51Triple Negative Breast Neoplasms 50Lymphoma 50Hematologic Neoplasms 47Glioma 46Esophageal Neoplasms 46Colonic Neoplasms 46Small Cell Lung Carcinoma 43

Interventions

cemiplimab 1cabozantinib 1Specimen Handling 1Magnetic Resonance Spectroscopy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Recruiting × Adrenocortical Carcinoma × 30 days × Clear all
NCT06487481 2026-06-05

Study of Preoperative Radiation Therapy in Participants With Resectable Recurrent Abdominal Adrenocortical Carcinoma

National Institutes of Health Clinical Center (CC)

Phase 1 Recruiting
32 enrolled
Endocrine

Adrenocortical Carcinoma

NCT06900595 2026-05-22

Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescents and Adults With Advanced Adrenocortical Cancer

National Cancer Institute (NCI)

Phase 2 Recruiting
48 enrolled
Endocrine

Adrenocortical Carcinoma

NCT07189403 2026-05-22

A Study of DS9051b in Participants With Advanced or Metastatic Adrenocortical Carcinoma and Metastatic Castration-resistant Prostate Cancer

Daiichi Sankyo

Phase 1 Recruiting
40 enrolled
Endocrine

Adrenocortical Carcinoma

NCT00453674 2026-05-07

German Adrenocortical Carcinoma Registry

University of Wuerzburg

Recruiting
1,000 enrolled
Endocrine

Adrenal Gland Neoplasms, Adrenocortical Carcinoma

NCT00669266 2026-05-07

Adrenal Tumors - Pathogenesis and Therapy

University of Wuerzburg

Recruiting
500 enrolled
Endocrine

Adrenal Gland Neoplasms, Cushing Syndrome, Hyperaldosteronism, Pheochromocytoma, Adrenocortical Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡